Neuromuscular blockade.
D000769:Anesthesia, Inhalation; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004336:Drug Antagonism; D004357:Drug Synergism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006947:Hyperkalemia / Q000503:physiopathology; D009157:Myasthenia Gravis / Q000503:physiopathology; D009388:Neostigmine / Q000008:administration & dosage / Q000494:pharmacology; D009466:Neuromuscular Blocking Agents / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects*; D010197:Pancuronium / Q000494:pharmacology; D011729:Pyridostigmine Bromide / Q000008:administration & dosage / Q000494:pharmacology; D013390:Succinylcholine / Q000008:administration & dosage; D014882:Water-Electrolyte Balance
D000889:Anti-Arrhythmia Agents; D000900:Anti-Bacterial Agents; D002800:Cholinesterase Inhibitors; D009466:Neuromuscular Blocking Agents; D009467:Neuromuscular Depolarizing Agents; D009388:Neostigmine; D013390:Succinylcholine; D010197:Pancuronium; D011729:Pyridostigmine Bromide